Infectious complications following pancreatic transplantation: Incidence, microbiological and clinical characteristics, and outcome

Clinical Infectious Diseases

Volumn 20, Issue 3, 1995, Pages 514-520

  Lumbreras, C ^a   Fernandez, I ^a   Velosa, J ^a   Munn, S ^a   Sterioff, S ^a   Paya, C V ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; AMPHOTERICIN B; ANTIBIOTIC AGENT; AZATHIOPRINE; CEFOTAXIME; CORTICOSTEROID; COTRIMOXAZOLE; CYCLOSPORIN; GANCICLOVIR; GENTAMICIN; LYMPHOBLAST ANTIBODY; METRONIDAZOLE; NEOMYCIN; NEOSPORIN; NYSTATIN; OKT 3; POLYMYXIN; POLYMYXIN B; SULFAMETHOXAZOLE; TRIMETHOPRIM; VANCOMYCIN;

ABDOMINAL INFECTION; ADULT; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTERIAL INFECTION; CLINICAL ARTICLE; CYTOMEGALOVIRUS INFECTION; DRUG MIXTURE; EPSTEIN BARR VIRUS; FEMALE; GRAFT REJECTION; HERPES SIMPLEX VIRUS; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INFECTIOUS COMPLICATION; INTRAVENOUS DRUG ADMINISTRATION; LYMPHOPROLIFERATIVE DISEASE; MALE; MYCOSIS; ORAL DRUG ADMINISTRATION; PANCREAS TRANSPLANTATION; PNEUMOCYSTIS CARINII; PRIORITY JOURNAL; VARICELLA ZOSTER VIRUS; WOUND INFECTION;

ADOLESCENT; ADULT; BACTERIAL INFECTIONS; FEMALE; FOLLOW-UP STUDIES; HUMAN; INCIDENCE; INFECTION; MALE; MIDDLE AGE; MUROMONAB-CD3; MYCOSES; PANCREAS TRANSPLANTATION; POSTOPERATIVE COMPLICATIONS; TREATMENT OUTCOME; VIRUS DISEASES;

EID: 0028967818     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/clinids/20.3.514     Document Type: Article

References (26)

1. Sutherland DER, Dunn DL, Goetz FC, et al. A 10-year experience with 290 pancreas transplants at a single institution. Ann Surg 1989;210:274-88.
2. Kennedy WR, Navarro X. Goetz FC, Sutherland DER, Najarian JS. Effects of pancreatic transplantation on diabetic neuropathy. N Engl J Med 1990;322:1031-7.
3. Bilous RW, Mauer SM, Sutherland DER, Najarian JS, Goetz FC, Steffes MW. The effects of pancreas transplantation on the glomerular structure of renal allografts in patients with insulin-dependent diabetes. N Engl J Med 1989;321:80-5.
4. Bohman SO, Wilczek H, Tyden G, Jaremko G, Lyndgren G, Groth CG. Recurrent diabetic nephropathy in renal allografts placed in diabetic patients and protective effect of simultaneous pancreatic transplantation. Transplant Proc 1987;19:2290-2.
5. Sutherland DE, Gruber SA. Pancreas transplantation. Crit Care Clin 1990;6:947-53.
6. Sutherland DE. Pancreatic transplantation: state of the art. Transplant Proc 1992;24:762-6.
7. Remuzzi G, Ruggenenti P. Mauer SM. Pancreas and kidney/pancreas transplants: experimental medicine or real improvement? Lancet 1994;343:27-31.
8. Cheung AHS, Sutherland DER, Gillingham KJ. et al. Simultaneous pancreas-kidney transplant versus kidney transplant alone in diabetic patients. Kidney Int 1992;41:924-9.
9. Rosen CB, Frohnert PP. Velosa JA, Engen DA, Sterioff S. Morbidity of pancreas transplantation during cadaveric renal transplantation. Transplantation 1991;51:123-7.
10. Perkins JD, Frohnert PP, Service FJ, et al. Pancreas transplantation at Mayo: 111. Multidisciplinary management. Mayo Clin Proc 1990;65:496-508.
11. Perkins JD, Fromme GA, Narr BJ, et al. Pancreas transplantation at Mayo. II. Operative and perioperative management. Mayo Clin Proc 1990;65:483-95.
12. Paya CV, Hermans PE, Washington JA II, et al. Incidence, distribution and outcome of episodes of infection in 100 orthotopic liver transplantations. Mayo Clin Proc 1989;64:555-64.
13. Dummer JS. Infectious complications of transplantation. In: Thompson ME. ed. Cardiac transplantation. Philadelphia: FA Davis, 1990:163-78.
14. Sollinger HW, Knechtle SJ, Reed A, et al. Experience with 100 consecutive simultaneous kidney-pancreas transplants with bladder drainage. Ann Surg 1991;214:703-11.
15. Wiesner RH, Hermans PE, Rakela J, et al. Selective bowel decontamination to decrease gram-negative aerobic bacterial and Candida colonization and prevent infection after orthotopic liver transplantation. Transplantation 1988;45:570-4.
16. Hesse UJ, Sutherland DER, Najarian JS, Simmons RL. Intra-abdominal infections in pancreas transplant recipients. Ann Surg 1986;203:153-62.
17. Paya CV. Fungal infections in solid-organ transplantation. Clin Infect Dis 1993;16:677-88.
18. Ho M. Human cytomegalovirus infections in immunosuppressed patients. In: Ho M, ed. Cytomegalovirus: biology and infection. 2nd ed. New York: Plenum. 1991:249-300.
19. Dauber JH, Paradis IL, Dummer JS. Infectious complications in pulmonary allograft recipients. Clin Chest Med 1990; 11:291-308.
20. Singh N, Dummer JS, Kusne S, et al. Infections with cytomegalovirus and other herpes viruses in 121 liver transplant recipients: transmission by donated organ and the effect of OKT3 antibodies. J Infect Dis 1988;158:124-31.
21. Hibberd PL, Tolkoff-Rubin NE, Cossimi AB, et al. Symptomatic cytomegalovirus disease in the cytomegalovirus antibody seropositive renal transplant recipient treated with OKT3. Transplantation 1992;53:68-72.
22. Bia MJ, Flye MW. Immunoblastic lymphoma in a cyclosporine-treated renal transplant recipient. Transplantation 1985;39:673-5.
23. Penn I. Cancers following cyclosporine therapy. Transplantation 1987;43:32-5.
24. Swinnen LJ, Costanzo-Nordin MR, Fisher SG, et al. Increased incidence of lymphoproliferative disorder after immunosupression with the monoclonal antibody OKT3 in cardiac-transplant recipients. N Engl J Med 1990;323:1723-8.
25. Cohen JI. Epstein-Barr virus lymphoproliferative disease associated with acquired immunodeficiency. Medicine (Baltimore) 1991; 70:137-60.
26. Ho M, Miller G, Atchinson RW, et al. Epstein-Barr virus infections and DNA hybridization studies in post-transplantation lymphoma and lymphoproliferative lesions: the role of primary infection. J Infect Dis 1985;152:876-86.